New in the marketplace
- PDF / 59,928 Bytes
- 1 Pages / 592.44 x 751.18 pts Page_size
- 81 Downloads / 213 Views
New in the marketplace The following table contains a summary of product launches and approvals identified in international markets in recent weeks by the drug therapy reporting service Inpharma Weekly. Summarising information selected from over 1600 biomedical publications, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. Generic name Abarelix (A) Drospirenone/estradiol (A) Erlotinib ( L) Ibandronic acid (once-monthly, oral; L) Insulin glulisine (L) Melanoma vaccine DNP-VACC (L) Methyl aminolevulinate (A) Moxifloxacin (A) Nelarabine (A)
Trade name (Company) Indication/Category Country Plenaxis (Praecis Pharmaceuticals) Initiation of hormonal castration in advanced or metastatic, Germany hormone-dependent prostate cancer Angeliq (Berlex Inc) Treatment of moderate-to-severe vasomotor symptoms US associated with menopause Tarceva (OSI Pharmaceuticals, Treatment of non-small-cell lung cancer EU Roche) Bonviva (GlaxoSmithKline) Treatment of postmenopausal osteoporosis UK Apidra (sanofi-aventis) M-Vax (AVAX Technologies, Pro Vaccine AG) Metvix (PhotoCure) Avelox (Bayer Yakuhin, Shionogi) Arranor (GlaxoSmithKline)
Treatment of diabetes mellitus Treatment of melanoma
Omega-3 ethylester concentrate (L) Palifermin (A) Posaconazole (A)
Treatment of actinic keratosis and basal cell cancer Antibacterial Treatment of T-cell acute lymphoblastic leukaemia and T-Cell lymphoblastic lymphoma Omacor (Reliant Pharmaceuticals) Adjunct to diet for the treatment of very high triglyceride levels Kepivance (Amgen) Treatment of oral mucositis in certain patients Noxafil (Schering-Plough) Treatment of invasive fungal infections
Pregabalin (L)
Lyrica (Pfizer)
Ramelteon (L) Tipranavir (A) A = approved; L = launched.
UK Switzerland Brazil Japan US US EU EU, Norway, Iceland US
Treatment of neuropathic pain (diabetic peripheral neuropathy or postherpetic neuralgia) Adjunctive treatment of partial epileptic seizures in adults Rozerem (Takeda Pharmaceuticals Treatment of insomnia characterised by difficulty with US North America) sleep onset Aptivus (Boehringer Ingelheim) Treatment of HIV infection EU
Drugs Ther Perspect 2005; Vol. 21, No. 12
Data Loading...
